Giving Kyzatrex® renewed energy and vibrance with a new brand campaign

madman

Super Moderator

Situation​

More than 20 million men deal with problems related to hypogonadism, or low testosterone. Many patients and HCPs have preconceived notions about diagnosis and treatment, and tend to focus solely on sexual health benefits. But low testosterone can also contribute to health problems ranging from mild issues such as fatigue, to severe problems including obesity, type 2 diabetes, CVD and mental illness.

Testosterone replacement therapy (TRT) is an emerging market that still falls to the bottom of the priority list for many HCPs.
Despite its prevalence and chronicity, the diagnosis, administration and management of TRT remains a complex journey that, until Kyzatrex®, only came in painful, inconvenient or messy treatment options. Kyzatrex, however, brought an innovative new approach to the market by providing the option of helping patients address this important metabolic issue with a convenient daily oral dose — a difference that HCPs needed to be aware of.





To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.
 

Online statistics

Members online
3
Guests online
190
Total visitors
193

Latest posts

Back
Top